We failed to demonstrate a significant association between insulin secretagogue therapy and beta-cell function in our study cohort.
In the controlled phase of this study, we failed to demonstrate that DBS improved chronic CH when compared with sham stimulation.
However, we failed to demonstrate a prognostic value for Δ%SUVmax, Δ%SUVmean or Δ%TV, showing similar evolution of these quantitative parameters whatever the tumour response to treatment.
This issue was specifically evaluated, and in spite of the overall great interest reported in the general population, we failed to demonstrate an effect in the results, in contrast with previous studies reporting better results in trainees with higher interest in surgery [27].
With respect to preventing suicide, the Journal of Affective Disorders in 1999 ("Retrospective Controlled Study of Inpatient ECT: Does it Prevent Suicide?") reported, "We failed to demonstrate that ECT had prevented suicide in hospitalized patients".
We failed to demonstrate strong Gli1 protein expression in the xenograft tissue (data not shown).
However, we failed to demonstrate interactions between DID-DD and bridge element in solution NMR experiments.
Also, we failed to demonstrate any change in the toxicity induced by the m8 mutant in this strain.
However, we failed to demonstrate any effect of the book on disability and pain level in patients reporting persistent pain and, as others, on work absenteeism [29].
We failed to demonstrate any improvement on cardiac function in animals that receive BMC by the IV route while others have succeeded [41] [43].
Indeed we failed to demonstrate PrPres in the urine in the present case even after hundred-fold urine concentration (data not shown).
